Document Detail


Respiratory muscle pressures in non-CF bronchiectasis: repeatability and reliability.
MedLine Citation:
PMID:  20688894     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Respiratory muscle strength is used diagnostically in clinical practice and as an outcome measure in clinical trials in various chronic lung diseases. There is limited data on its repeatability in people with non-CF bronchiectasis. The aim of the present study was to assess the repeatability of maximal inspiratory (P( I)max) and expiratory pressures (P(E)max) in a group of patients with stable, moderate-to-severe non-CF bronchiectasis.
METHODS: Twenty participants with stable moderate-to-severe non-CF bronchiectasis were recruited. Respiratory muscle strength measurements (three maximal inspiratory and expiratory pressures) were made on 2 separate days. A standard protocol was used, including practice tests, before obtaining three technically acceptable and reproducible readings with a difference of 10% or less between values.
CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT00487149.
RESULTS: The mean (SD) age of the non-CF bronchiectasis group was 63 (9) years. Maximal inspiratory pressures were repeatable with mean (SD) for highest P(I)max, Test 1 and Test 2, 75.90 (20) and 79.40 (19) cmH(2)O, and limits of agreement (mean difference +/- 2SD) -3.50 +/- 20 cmH(2)O, (p = 0.14). Maximal expiratory pressures differed significantly with mean (SD) for highest P(E)max, Test 1 and Test 2, 102.25 (27) and 112.30 (32) cmH(2)O, and limits of agreement (mean difference +/- 2SD) -10.10 +/- 35 cmH(2)O, (p = 0.02). The intraclass correlation coefficient (95% CI) for highest P(I)max and P(E)max was 0.93 (95% CI 0.82 to 0.97) and 0.90 (95% CI 0.76 to 0.96), respectively.
CONCLUSION: Maximal inspiratory pressure measurements were repeatable during a period of clinical stability in moderate-to-severe non-CF bronchiectasis, suggesting this may be a useful outcome measure in non-CF bronchiectasis. Once a baseline has been established, a second visit is not required. P(E)max was not a repeatable measure and further study is necessary to ascertain how much practice testing is required to obtain an accurate value.
Authors:
F Moran; A Piper; J S Elborn; J M Bradley
Related Documents :
6696234 - Oxygen drive to breathing during halothane anesthesia: effects of almitrine bismesilate.
2611084 - Cardiogenic mixing: mechanisms and experimental evidence in dogs.
24307714 - Cerebrospinal fluid pressure and glaucoma: regulation of trans-lamina cribrosa pressure.
7204194 - Perception of changes in breathing in normal human subjects.
15876784 - An experimental study of apico-aortic valved conduit (aavc) for surgical treatment of a...
16423674 - Early mitral filling/diastolic mitral annular velocity ratio is not a reliable predicto...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Chronic respiratory disease     Volume:  7     ISSN:  1479-9731     ISO Abbreviation:  Chron Respir Dis     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-06     Completed Date:  2010-12-08     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  101197408     Medline TA:  Chron Respir Dis     Country:  England    
Other Details:
Languages:  eng     Pagination:  165-71     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bronchiectasis / physiopathology*
Female
Forced Expiratory Volume / physiology
Humans
Male
Middle Aged
Muscle Strength / physiology*
Reproducibility of Results
Respiration
Respiratory Muscles / physiology*
Severity of Illness Index
Spirometry

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effectiveness of a group opt-in session on uptake and graduation rates for pulmonary rehabilitation.
Next Document:  Differentiating between IPF and NSIP.